Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,345 | 80 | 88.9% |
| Travel and Lodging | $514.22 | 2 | 10.5% |
| Education | $27.32 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $931.46 | 10 | $0 (2023) |
| Novo Nordisk Inc | $761.74 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $719.03 | 10 | $0 (2024) |
| Amgen Inc. | $386.73 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $367.74 | 11 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $356.83 | 6 | $0 (2023) |
| Vifor Pharma, Inc. | $293.48 | 5 | $0 (2024) |
| GENZYME CORPORATION | $268.92 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $143.79 | 2 | $0 (2024) |
| Baxter Healthcare | $136.59 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.08 | 6 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $2,327 | 41 | Medtronic, Inc. ($828.41) |
| 2022 | $925.54 | 15 | Vifor Pharma, Inc. ($169.11) |
| 2021 | $1,131 | 19 | Novo Nordisk Inc ($516.18) |
| 2020 | $21.96 | 1 | AstraZeneca Pharmaceuticals LP ($21.96) |
| 2018 | $18.79 | 1 | GlaxoSmithKline, LLC. ($18.79) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/28/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Nephrology | ||||||
| 05/28/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $124.37 | General |
| Category: Hyperkalemia | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $31.32 | General |
| 11/15/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Bone Health | ||||||
| 11/09/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $81.96 | General |
| Category: Surgical Care | ||||||
| 10/25/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $54.63 | General |
| Category: Surgical Care | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Travel and Lodging | In-kind items and services | $438.00 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $81.10 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Travel and Lodging | In-kind items and services | $76.22 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $67.05 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $40.54 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $40.54 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $39.11 | General |
| Category: Catheters | ||||||
| 10/20/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Catheters | ||||||
| 10/13/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $124.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 75 | 234 | $114,073 | $30,936 |
| 2022 | 5 | 114 | 375 | $193,333 | $55,774 |
| 2021 | 6 | 146 | 443 | $231,930 | $69,627 |
| 2020 | 5 | 151 | 347 | $194,143 | $56,709 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Facility | 2023 | 15 | 87 | $55,112 | $15,788 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 98 | $25,163 | $7,028 | 27.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 30 | $24,420 | $5,847 | 23.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 19 | $9,378 | $2,272 | 24.2% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Facility | 2022 | 22 | 144 | $86,832 | $27,502 | 31.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 78 | $66,066 | $16,121 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 127 | $26,487 | $8,206 | 31.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $7,637 | $2,414 | 31.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 13 | $6,311 | $1,532 | 24.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Facility | 2021 | 27 | 197 | $118,200 | $37,846 | 32.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 27 | 74 | $62,670 | $15,598 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 120 | $25,174 | $8,015 | 31.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2021 | 14 | 17 | $14,875 | $4,759 | 32.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 19 | 19 | $6,251 | $1,858 | 29.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 16 | $4,760 | $1,551 | 32.6% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Facility | 2020 | 31 | 107 | $58,315 | $18,577 | 31.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 35 | 87 | $72,993 | $18,176 | 24.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Facility | 2020 | 29 | 57 | $40,242 | $12,872 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 77 | $16,342 | $5,219 | 31.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 19 | 19 | $6,251 | $1,865 | 29.8% |
About Jamil Ibrahim
Jamil Ibrahim is a Critical Care Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1306267745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jamil Ibrahim has received a total of $4,886 in payments from pharmaceutical and medical device companies, with $462.08 received in 2024. These payments were reported across 83 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,345).
As a Medicare-enrolled provider, Ibrahim has provided services to 486 Medicare beneficiaries, totaling 1,399 services with total Medicare billing of $213,046. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Nephrology
- Location Brooklyn, NY
- Active Since 01/03/2014
- Last Updated 04/15/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306267745
Products in Payments
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $931.46
- Ozempic (Drug) $648.61
- LOKELMA (Drug) $461.42
- OFEV (Drug) $367.74
- LUPKYNIS (Drug) $356.83
- FARXIGA (Drug) $257.61
- Aranesp (Biological) $183.20
- ENJAYMO (Biological) $148.23
- Veltassa (Drug) $144.28
- AREXVY (Drug) $125.00
- LifeVest (Device) $124.58
- EVENITY (Biological) $124.12
- JEVTANA (Drug) $120.69
- XARELTO (Drug) $107.88
- DUPIXENT (Biological) $106.05
- Rybelsus (Drug) $95.76
- Velphoro (Drug) $47.46
- Parsabiv (Drug) $45.31
- KRYSTEXXA (Biological) $34.10
- JYNARQUE (Drug) $25.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Brooklyn
Dr. Joshua Rosenberg, M.d, M.D
Critical Care Medicine — Payments: $893,165
Dr. Aaliya Burza, M.d, M.D
Critical Care Medicine — Payments: $54,441
Dr. Keerthana Keshava, M.b.b.s, M.B.B.S
Critical Care Medicine — Payments: $23,722
Dr. Yizhak Kupfer, Md, MD
Critical Care Medicine — Payments: $22,120
Mediha Ibrahim, M.d, M.D
Critical Care Medicine — Payments: $14,961
Igor Chernyavskiy, M.d, M.D
Critical Care Medicine — Payments: $7,598